跳至主要内容
临床试验/NCT02265562
NCT02265562Unknown3 期

Evaluation of the Effect of Rectal Misoprostol on Blood Loss During Abdominal Hysterectomy: A Double Blind Randomized Controlled Trial.

Cairo University1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
220
试验地点
1
主要终点
Blood loss

研究概览

简要总结

Hysterectomy, as any major operation, can cause complications, as hemorrhage which may occur in some cases and sometimes requiring blood transfusion. Recent study proved that misoprostol success in reducing blood loss during total abdominal hysterectomy when used once before the surgery.

详细描述

In this study we tried to assess the efficacy of misoprostol in minimize blood loss during hysterectomy when used as single preoperative dose via rectal route. The reduction of blood flow may be due to the combined effect of myometrial contraction and vasoconstrictive effect

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • A- Age: adult female >18 years old. B- Any women undergoing abdominal hysterectomy. C- No contraindications to misoprostol.

排除标准

  • A -Women with any contraindications to misoprostol including heart disease, mitral stenosis , severe hypertension ( diastolic pressure over100mm Hg) , hematologic disorders (as sickle cell anemia ), glaucoma, bronchial asthma, liver disease.
  • B- Known history of or active medical disorder as DM . C- Pelvic endometriosis and adnexal mass. D- Those who had undergone previous myomectomy. E- Women who received GnRH analogues and mifepristone and who are allergic to prostaglandins.
  • F- Women with mental impairment or incompetent in giving consent. G- Women who don't wish to participate in the study.

研究组 & 干预措施

Misoprostol

Experimental

60 minutes before the surgery 400 μg of misoprostol (2 tablets of 200 μg) inserted rectally

干预措施: Misoprostol (Drug)

Placebo

Placebo Comparator

60 minutes before the surgery 2 tablets of placebo tablets inserted rectally

干预措施: Placebo (Drug)

结局指标

主要结局

Blood loss

时间窗: 8 months

amount of intra-operative blood loss

次要结局

  • postoperative hemoglobin level(8 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Waleed El-khayat

Assistant Professor of Obstetrics & Gynecology

Cairo University

研究点 (1)

Loading locations...

相似试验